Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)

Bridges, Carolyn B.; Cox, Nancy (Nancy J.); Fukuda, Keiji; Harper, Scott A.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Superseded

This Document Has Been Replaced By: Prevention and control of seasonal influenza with vaccines : recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 influenza season

Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)

September 26, 2003
By Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; ...
Series: MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-13

[PDF-256.79 KB]

English

Details You May Also Like

Details:

Personal Author:

Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; Harper, Scott A.

Bridges, Carolyn B. ; Cox, Nancy (Nancy J.) ; Fukuda, Keiji ; Harper, Scott A. Less -
Corporate Authors:

United States. Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division.

United States. Advisory Committee on Immunization Practices. ; National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. ; National Immunization Program (Centers for Disease Control and Prevention), Epidemiology and Surveillance Division. Less -
Description:

This report summarizes recommendations by the Advisory Committee on Immunization Practices (ACIP) for using intranasally administered, trivalent, cold-adapted, live, attenuated influenza vaccine (LAIV), which was approved for use in the United States on June 17, 2003 (FluMist trade mark, produced by MedImmune, Inc., Gaithersburg, Maryland). LAIV is currently approved for use among healthy persons (i.e., those not at high risk for complications from influenza infection) aged 5-49 years. This report includes information regarding 1) vaccine composition and mechanisms of action; 2) comparison between LAIV and trivalent inactivated influenza vaccine; 3) effectiveness and safety of LAIV; 4) transmission and stability of LAIV viruses; 5) recommendations and contraindications for using LAIV; and 6) dosage and administration of LAIV. This report supplements the 2003 ACIP recommendations regarding prevention and control of influenza (CDC. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2003;52[No. RR-8]:1-36.)
Content Notes:

prepared by Scott A. Harper, Keiji Fukuda, Nancy J. Cox, Carolyn B. Bridges.

The material is this report originated in the National Center for Infectious Diseases, Division of Viral and Rickettsial Diseases; and the National Immunization Program, Epidemiology and Surveillance Division.

Includes bibliographical references and index (p. 7-8).

1/13/2014

JCSmith
Subjects:

[+]

Influenza, Human/prevention & Control Influenza Vaccines/administration & Dosage Influenza Vaccines/adverse Effects Influenza Vaccines/contraindications Vaccination/standards Vaccines, Attenuated
Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 52, no. RR-13
Pubmed ID:

14557799
Document Type:

Journal Issue
Genre:

Practice Guideline
Pages in Document:

print; 8 p. ; 28 cm.
Collection(s):

Advisory Committee on Immunization Practices (ACIP) Stephen B. Thacker CDC Library collection Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:98a2dbd5f550326e670ffdfd9174135574d663f4b813ff1fbd9fcb7d60b0728c
Download URL:

https://stacks.cdc.gov/view/cdc/13510/cdc_13510_DS1.pdf
File Type:

No Additional Files

More +

Superseded

Using live, attenuated influenza vaccine for prevention and control of influenza; supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP)

Details:

Supporting Files

You May Also Like